Basic Study
Copyright ©The Author(s) 2025.
World J Hepatol. Jul 27, 2025; 17(7): 106151
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.106151
Figure 7
Figure 7 Clinical significance of E2F transcription factor 1 dysregulation in hepatocellular carcinoma: Expression patterns and survival implications. A: Transcriptional overexpression of E2F transcription factor 1 (E2F1) mRNA in hepatocellular carcinoma vs non-tumorous liver tissues; B–D: Prognostic stratification using Kaplan–Meier Plotter survival analytics including overall survival, progression-free survival, recurrence-free survival (log-rank P < 0.01). E2F1: E2F transcription factor 1; OS: Overall survival; PFS: Progression-free survival; RFS: Recurrence-free survival.